These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33368640)

  • 21. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
    Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S
    BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis.
    Zou X; Gao F; Wang ZY; Zhang H; Liu QX; Jiang L; Zhou X; Zhu W
    Chin Med J (Engl); 2020 Nov; 133(21):2543-2551. PubMed ID: 33009019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
    Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
    Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
    Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
    Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
    J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
    Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
    Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
    Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 29. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
    Li R; Liu J; Li Q; Chen G; Yu X
    Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.
    Wang J; Zhou Y; Lu J; Sun Y; Xiao H; Liu M; Tian L
    Med Oncol; 2014 Sep; 31(9):148. PubMed ID: 25099764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
    Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
    PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
    J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
    Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z
    Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.
    Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B
    OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer.
    Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
    Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.
    Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X
    World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.